Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Accured Expenses (2016 - 2025)

RedHill Biopharma has reported Change in Accured Expenses over the past 12 years, most recently at $456000.0 for Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A to $456000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $456000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $456000.0 for FY2025, 85.01% down from the prior year.
  • Change in Accured Expenses was $456000.0 for Q4 2025 at RedHill Biopharma, up from -$3.2 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $3.3 million in Q1 2022 and troughed at -$3.2 million in Q4 2022.
  • The 3-year median for Change in Accured Expenses is $309000.0 (2021), against an average of -$437333.3.
  • The largest YoY upside for Change in Accured Expenses was 138.64% in 2022 against a maximum downside of 1151.78% in 2022.
  • A 3-year view of Change in Accured Expenses shows it stood at $309000.0 in 2021, then tumbled by 1151.78% to -$3.2 million in 2022, then soared by 114.03% to $456000.0 in 2025.
  • Per Business Quant, the three most recent readings for RDHL's Change in Accured Expenses are $456000.0 (Q4 2025), -$3.2 million (Q4 2022), and $987000.0 (Q3 2022).